While Beta Bionics Inc has underperformed by -3.65%, investors are advised to look at stock chart patterns for technical insight.
On February 24, 2025, Stifel started tracking Beta Bionics Inc (NASDAQ: BBNX) recommending Buy. A report published by Piper Sandler on February 24, 2025, Initiated its previous ‘Overweight’ rating for BBNX. Leerink Partners also rated BBNX shares as ‘Outperform’, setting a target price of $28 on the company’s shares in an initiating report dated February 24, 2025. Lake Street Initiated an Buy rating on February 24, 2025, and assigned a price target of $30. BofA Securities initiated its ‘Buy’ rating for BBNX, as published in its report on February 24, 2025. Robert W. Baird’s report from February 20, 2025 suggests a price prediction of $20 for BBNX shares, giving the stock a ‘Neutral’ rating. Ladenburg Thalmann also rated the stock as ‘Neutral’.
Analysis of Beta Bionics Inc (BBNX)
In order to gain a clear picture of Beta Bionics Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. Taking into account the quick ratio of the company, currently set at 5.66, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
An average volume of 648.63K can be a very valuable indicator of volatility for BBNX stock. On a monthly basis, the volatility of the stock is set at 10.13%, whereas on a weekly basis, it is put at 10.48%, with a loss of -19.25% over the past seven days. Furthermore, long-term investors anticipate a median target price of $25.71, showing growth from the present price of $12.67, which can serve as yet another indication of whether BBNX is worth investing in or should be passed over.
How Do You Analyze Beta Bionics Inc Shares?
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 18.78%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 38.03% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
BBNX shares are owned by institutional investors to the tune of 38.03% at present.
